These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31562633)

  • 1. Overview of Lipid Biomarkers in Amyotrophic Lateral Sclerosis (ALS).
    Trostchansky A
    Adv Exp Med Biol; 2019; 1161():233-241. PubMed ID: 31562633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is magnetic resonance imaging a plausible biomarker for upper motor neuron degeneration in amyotrophic lateral sclerosis/primary lateral sclerosis or merely a useful paraclinical tool to exclude mimic syndromes? A critical review of imaging applicability in clinical routine.
    Rocha AJ; Maia Júnior AC
    Arq Neuropsiquiatr; 2012 Jul; 70(7):532-9. PubMed ID: 22836461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse Model.
    Sheean RK; McKay FC; Cretney E; Bye CR; Perera ND; Tomas D; Weston RA; Scheller KJ; Djouma E; Menon P; Schibeci SD; Marmash N; Yerbury JJ; Nutt SL; Booth DR; Stewart GJ; Kiernan MC; Vucic S; Turner BJ
    JAMA Neurol; 2018 Jun; 75(6):681-689. PubMed ID: 29507931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are Circulating Cytokines Reliable Biomarkers for Amyotrophic Lateral Sclerosis?
    Moreno-Martinez L; Calvo AC; Muñoz MJ; Osta R
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.
    Vu LT; Bowser R
    Neurotherapeutics; 2017 Jan; 14(1):119-134. PubMed ID: 27933485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrient Effects on Motor Neurons and the Risk of Amyotrophic Lateral Sclerosis.
    Goncharova PS; Davydova TK; Popova TE; Novitsky MA; Petrova MM; Gavrilyuk OA; Al-Zamil M; Zhukova NG; Nasyrova RF; Shnayder NA
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis Diagnosis.
    Mitropoulos K; Katsila T; Patrinos GP; Pampalakis G
    OMICS; 2018 Jan; 22(1):52-64. PubMed ID: 29356625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurophysiological biomarkers in amyotrophic lateral sclerosis.
    Vucic S; Rutkove SB
    Curr Opin Neurol; 2018 Oct; 31(5):640-647. PubMed ID: 30080715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
    Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
    J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis.
    Pampalakis G; Mitropoulos K; Xiromerisiou G; Dardiotis E; Deretzi G; Anagnostouli M; Katsila T; Rentzos M; Patrinos GP
    Hum Mutat; 2019 Apr; 40(4):361-373. PubMed ID: 30556231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral factors in ALS patients during disease progression.
    Ehrhart J; Smith AJ; Kuzmin-Nichols N; Zesiewicz TA; Jahan I; Shytle RD; Kim SH; Sanberg CD; Vu TH; Gooch CL; Sanberg PR; Garbuzova-Davis S
    J Neuroinflammation; 2015 Jun; 12():127. PubMed ID: 26126965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonizing bone morphogenetic protein 4 attenuates disease progression in a rat model of amyotrophic lateral sclerosis.
    Shijo T; Warita H; Suzuki N; Ikeda K; Mitsuzawa S; Akiyama T; Ono H; Nishiyama A; Izumi R; Kitajima Y; Aoki M
    Exp Neurol; 2018 Sep; 307():164-179. PubMed ID: 29932880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating cell-free DNA as potential diagnostic tools for amyotrophic lateral sclerosis.
    Robichaud PP; Arseneault M; O'Connell C; Ouellette RJ; Morin PJ
    Neurosci Lett; 2021 Apr; 750():135813. PubMed ID: 33705931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models.
    Hoye ML; Koval ED; Wegener AJ; Hyman TS; Yang C; O'Brien DR; Miller RL; Cole T; Schoch KM; Shen T; Kunikata T; Richard JP; Gutmann DH; Maragakis NJ; Kordasiewicz HB; Dougherty JD; Miller TM
    J Neurosci; 2017 May; 37(22):5574-5586. PubMed ID: 28416596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoids and related lipids in serum from patients with amyotrophic lateral sclerosis.
    Carter GT; McLaughlin RJ; Cuttler C; Sauber GJ; Weeks DL; Hillard CJ; Weiss MD
    Muscle Nerve; 2021 Jan; 63(1):120-126. PubMed ID: 33094490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein biomarkers for amyotrophic lateral sclerosis.
    Ryberg H; Bowser R
    Expert Rev Proteomics; 2008 Apr; 5(2):249-62. PubMed ID: 18466055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining pre-symptomatic amyotrophic lateral sclerosis.
    Benatar M; Turner MR; Wuu J
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):303-309. PubMed ID: 30892087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the gene expression associated to amyotrophic lateral sclerosis.
    Recabarren-Leiva D; Alarcón M
    Life Sci; 2018 Jan; 193():110-123. PubMed ID: 29241710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.